Variability in the Prevalence of Microsatellite Instability in Colon Cancer

Main Article Content

Brad David Barrows Neda Zarrin-Khameh


BACKGROUND – Microsatellite instability is an important contributor to sporadic and familial colon cancer. Dysfunction of DNA mismatch-repair proteins by mutation or promoter methylation is a well-recognized cause of microsatellite instability. We conducted a study to identify variations in the prevalence of mismatch-repair protein deficiency in colon cancer and analyze clinical characteristics that may contribute to differences among ethnic subgroups of a community hospital-based patient population.

METHOD – A retrospective analysis of 272 cases was performed.

RESULTS – Reduced prevalence of mismatch-repair protein dysfunction was found in all non-Latino ethnicities (3.6%) compared to the Latino (13.1%) portion of our patient population (p=0.007). Mismatch repair protein deficient colon cancer was found to show significant correlation with right side location (p=0.017), young age in non-Latino ethnicities (p=0.030), tumor stage IIIC or greater (p=0.006), and high-grade histology (p=0.003). Colon cancer patients of Latino descent appear to have an increased rate of germline mutations within mismatch repair genes.

CONCLUSION – The prevalence of mismatch repair protein dysfunction in the non-Latino ethnicities of our patient population are less than reported in literature, while the rate of germline mutations within mismatch repair genes appears increased in those of Latino descent.

Article Details

How to Cite
BARROWS, Brad David; ZARRIN-KHAMEH, Neda. Variability in the Prevalence of Microsatellite Instability in Colon Cancer. Medical Research Archives, [S.l.], v. 5, n. 4, apr. 2017. ISSN 2375-1924. Available at: <>. Date accessed: 25 mar. 2023.
Colon cancer, MSI, Immunohistochemical Stain
Research Articles


1. Hartman DJ, Brand RE, Hu Het al. Lynch syndrome-associated colorectal carcinoma: frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach. Hum Pathol. 2013;44:2518-28.
2. Plummer JM, Chin SN, Aronson Met al. Lynch syndrome in a predominantly Afrocentric population: a clinicopathological and genetic study. Can J Surg. 2012;55:294-300.
3. Gologan A, Sepulveda AR. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers. Clin Lab Med. 2005;25:179-96.
4. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev. 1999;9:89-96.
5. Lipkin SM, Wang V, Jacoby R et al. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet. 2000;24:27-35.
6. Silva FC, Valentin MD, Ferreira Fde O et al. Mismatch repair genes in Lynch syndrome: a review. Sao Paulo Med J. 2009;127:46-51.
7. Halvarsson B, Lindblom A, Rambech E et al. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Arch. 2004;444:135-41.
8. Serrano M, Lage P, Belga S, Filipe B et al. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome. Fam Cancer. 2012;11:571-8.
9. Lynch HT, Lynch PM, Lanspa SJ et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76:1-18.
10. De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R et al. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer. 2010;9:155-66.
11. Ashktorab H, Brim H, Al-Riyami M et al. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects. Dig Dis Sci. 2008;53:2723-31.
12. Jin HY, Liu X, Li VK et al. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer. BMC Cancer. 2008;8:44.
13. Ashktorab H, Smoot DT, Farzanmehr H et al. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer. 2005;116:914-9.
14. Hatch SB, Lightfoot HM, Jr., Garwacki CP et al. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors. Clin Cancer Res. 2005;11:2180-7.
15. Cheah PL, Looi LM, Teoh KH et al. Colorectal carcinoma in Malaysians: DNA mismatch repair pattern in a multiethnic population. Asian Pac J Cancer Prev. 2014;15:3287-91.
16. Gupta S, Ashfaq R, Kapur P et al. Microsatellite instability among individuals of Hispanic origin with colorectal cancer. Cancer. 2010;116:4965-72.
17. Ashktorab H, Smoot DT, Carethers JM et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003;9:1112-7.
18. Bosman FT, Carneiro F, Hruban RH et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. 4 ed: World Heath Organization; 2010:418.
19. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-94.
20. Edge E, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual, 2nd edition. Springer; 2011:649.
21. Yearsley M, Hampel H, Lehman A et al. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol. 2006;37:831-8.
22. Society AC. Cancer Facts and Figures 2013. 2014 vol. 2013 ed. Corporate Center: American Cancer Society Inc: American Cancer Society; 2013.
23. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609-18.
24. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4:1-6.
25. Anthoney DA, McIlwrath AJ, Gallagher WM et al. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 1996;56:1374-81.
26. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829-34.
27. Kheirelseid EA, Miller N, Chang KH et al. Mismatch repair protein expression in colorectal cancer. J Gastrointest Oncol. 2013;4:397-408.
28. Hampel H, Frankel WL, Martin E et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-60.
29. Barnetson RA, Tenesa A, Farrington SM et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354:2751-63.